ISO 5058-1:2021

INTERNATIONAL ISO
STANDARD 5058-1
First edition
2021-11
Biotechnology — Genome editing —
Part 1:
Vocabulary
Biotechnologie — Édition génomique —
Partie 1: Vocabulaire
Reference number
© ISO 2021
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication may
be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on
the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address below
or ISO’s member body in the country of the requester.
ISO copyright office
CP 401 • Ch. de Blandonnet 8
CH-1214 Vernier, Geneva
Phone: +41 22 749 01 11
Email: copyright@iso.org
Website: www.iso.org
Published in Switzerland
ii
Contents Page
Foreword .iv
Introduction .v
1 Scope . 1
2 Normative references . 1
3 Terms and definitions . 1
3.1 Genome editing concepts . 1
3.2 Genome editing tools . 3
3.2.1 General . 3
3.2.2 CRISPR specific . 3
3.2.3 Meganuclease specific . 5
3.2.4 megaTAL specific . 5
3.2.5 TALEN specific . 6
3.2.6 ZFN specific . . 6
3.3 Genome editing outcomes . 7
4 Abbreviated terms . 8
Bibliography . 9
Index .10
iii
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out
through ISO technical committees. Each member body interested in a subject for which a technical
committee has been established has the right to be represented on that committee. International
organizations, governmental and non-governmental, in liaison with ISO, also take part in the work.
ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of
electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are
described in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the
different types of ISO documents should be noted. This document was drafted in accordance with the
editorial rules of the ISO/IEC Directives, Part 2 (see www.iso.org/directives).
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. ISO shall not be held responsible for identifying any or all such patent rights. Details of
any patent rights identified during the development of the document will be in the Introduction and/or
on the ISO list of patent declarations received (see www.iso.org/patents).
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and
expressions related to conformity assessment, as well as information about ISO’s adherence to
the World Trade Organization (WTO) principles in the Technical Barriers to Trade (TBT), see
www.iso.org/iso/foreword.html.
This document was prepared by Technical Committee ISO/TC 276, Biotechnology.
A list of all parts in the ISO 5058 series can be found on the ISO website.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www.iso.org/members.html.
iv
Introduction
Genome editing technology is a fast-growing and rapidly advancing global bioscience field with
applications in many biotechnology sectors. Genome editing is used to modify the nucleic acids of a
genetic code, which can be composed of DNA or RNA, in a site-specific manner. Modifications can include
insertion, deletion or alteration of nucleic acids. The technology operates by biochemical principles
generally applicable to every kind of cell. Examples of genome editing technology applications with
global significance include human cell-based therapeutics, agriculture, microbial based therapeutics,
synthetic biology and biomanufacturing.
While genome editing technology is being actively utilized, there is a need for international
standardization in terms and definitions for this field, so as to enhance interpretation and
communication of concepts, data and results.
This document has been developed to provide a unified standard set of terms and definitions that serve
the needs of biotechnology stakeholders and act as a reference for genome editing technology. Standards
in the field of genome editing are intended to harmonize and accelerate effective communication,
technology development, qualification and evaluation of genome editing products. This document is
expected to improve confidence in and clarity of scientific communication, data reporting and data
interpretation in the genome editing field. Specific requirements for the application of genome editing
technologies in agriculture and food are not included. For specific requirements, users can consult
standards developed by appropriate ISO Technical Committees, e.g. ISO/TC 34/SC 16 Horizontal
methods for molecular biomarker analysis, or ISO/TC 215 Health informatics.
This document provides a vocabulary that standardizes the use and meaning of terms associated with
genome editing. This document is organized into categories and sub-categories as follows:
— genome editing concepts (see 3.1);
— genome editing tools (see 3.2):
— general (see 3.2.1);
— CRISPR specific (see 3.2.2);
— meganuclease specific (see 3.2.3);
— megaTAL specific (see 3.2.4);
— TALEN specific (see 3.2.5);
— ZFN specific (see 3.2.6);
— genome editing outcomes (see 3.3).
Terms within categories are listed alphabetically. The sub-category “General” contains terms that
apply to all types of genome editing tools. Additional sub-categories contain terms specific to the sub-
category of genome editing technology: “CRISPR specific”, “Meganuclease specific”, “megaTAL specific”,
“TALEN specific” and “ZFN specific”. An alphabetical list of all terms is given in the index. Definitions
follow English word order wherever possible.
It is also recognized that genome editing is a rapidly developing and evolving biotechnology, and
additional terms and definitions will be needed as genome editing technologies mature.
v
INTERNATIONAL STANDARD ISO 5058-1:2021(E)
Biotechnology — Genome editing —
Part 1:
Vocabulary
1 Scope
This document defines terms related to genome editing technology.
This document is applicable to general use of genome editing across species.
2 Normative references
There are no normative references in this document.
3 Terms and definitions
ISO and IEC maintain terminological databases for use in standardization at the following addresses:
— ISO Online browsing platform: available at https:// www .iso .org/ obp
— IEC Electropedia: available at http:// www .electropedia .org/
3.1 Genome editing concepts
3.1.1
gene editing
techniques for genome engineering (3.1.3) that involve nucleic acid damage, repair mechanisms,
replication and/or recombination for incorporating site-specific modification(s) into a gene or genes
Note 1 to entry: Gene editing is a subclass of genome editing (3.1.2).
Note 2 to entry: There are various genome editing tools (see 3.2 and Figure 1).
3.1.2
genome editing
techniques for genome engineering (3.1.3) that involve nucleic acid damage, repair mechanisms,
replication and/or recombination for incorporating site-specific modification(s) into a genomic DNA
Note 1 to entry: Gene editing (3.1.1) is a subclass of genome editing.
Note 2 to entry: There are various genome editing tools (see 3.2 and Figure 1).
Figure 1 — Examples for genome editing technologies/tools
3.1.3
genome engineering
process of introducing intentional changes to genomic nucleic acid
Note 1 to entry: Gene editing (3.1.1) and genome editing (3.1.2) are techniques used in genome engineering.
3.1.4
off-target
genome editing off-target
genomic position and/or nucleic acid sequence distinct from the target (3.1.6)
EXAMPLE Off-target binding, off-target cleavage, off-target edit, off-target sequence change.
Note 1 to entry: An off-target edit is an example of an unintended edit (3.3.7).
3.1.5
specificity
genome editing target specificity
extent to which an editing agent or procedure acts only on its intended target (3.1.6)
Note 1 to entry: When using this term, the procedure is defined, the intended target is defined, the action or
outcome is measured and reported, and limits of detection are reported.
3.1.6
target
genome editing target
nucleic acid sequence subject to intentional binding, modification and/or cleavage during a genome
editing (3.1.2) process
Note 1 to entry: See also off-target (3.1.4), Cas nuclease target site (3.2.2.2), meganuclease target site (3.2.3.4),
megaTAL target site (3.2.4.3), TALEN target site (3.2.5.4) and ZFN target site (3.2.6.5).
3.2 Genome editing tools
3.2.1 General
3.2.1.1
repair template
nucleic acid sequence used to direct cellular DNA repair pathways to incorporate specific DNA sequence
changes at or near a target (3.1.6)
3.2.1.2
site-directed DNA modification enzyme
enzyme capable of modifying DNA at a specific sequence
EXAMPLE Site-directed nuclease (3.2.1.3), site-directed adenosine deaminase.
3.2.1.3
site-directed nuclease
sequence-specific nuclease
enzyme capable of cleaving the phosphodiester bond between adjacent nucleotides in a nucleic acid
polymer at a specific sequence
3.2.2 CRISPR specific
3.2.2.1
Cas nuclease
CRISPR associated nuclease
enzyme that is a component of CRISPR systems that is capable of breaking the phosphodiester bonds
between nucleotides
EXAMPLE Cas3, Cas9, Cas12a, Cas13, CasX.
Note 1 to entry: Some but
...